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Abstract
Background: Understanding injection practices is crucial for evidence-based development of intervention
initiatives. This study explored the extent of injection use and injection safety practices in primary care hospitals in
Bangladesh.
Methods: The study employed both quantitative and qualitative research methods. The methods used were - a
retrospective audit of prescriptions (n = 4320), focus group discussions (six with 43 participants), in-depth
interviews (n = 38) with a range service providers, and systematic observation of the activities of injection
providers (n = 120), waste handlers (n = 48) and hospital facilities (n = 24). Quantitative and qualitative data were
assessed with statistical and thematic analysis, respectively, and then combined.
Results: As many as 78% of our study sample (n = 4230) received an injection. The most commonly prescribed
injections (n = 3354) including antibiotics (78.3%), IV fluids (38.6%), analgesics/pain killers (29.4%), vitamins (26.7%),
and anti-histamines (18.5%). Further, 43.7% (n = 1145) of the prescribed antibiotics (n = 2626) were given to treat
diarrhea and 42.3% (n = 600) of IV fluids (n = 1295) were used to manage general weakness conditions. Nearly
one-third (29.8%; n = 36/120) of injection providers reported needle-stick injuries in the last 6 months with highest
incidences in Rajshahi division followed by Dhaka division. Disposal of injection needles, syringes and other
materials was not done properly in 83.5% (n = 20/24) of the facilities. Health providers’ safety concerns were not
addressed properly; only 23% (n = 28/120) of the health providers and 4.2% (n = 2/48) of the waste handlers were
fully immunized against Hepatitis B virus. Moreover, 73% (n = 87/120) of the injection providers and 90% (n = 43/
48) of the waste handlers were not trained in injection safety practices and infection prevention. Qualitative data
further confirmed that both providers and patients preferred injections, believing that they provide quick relief. The
doctors’ perceived injection use as their prescribing norm that enabled them to prove their professional credibility
and to remain popular in a competitive health care market. Additionally, persistent pressure from hospital
administration to use up injections before their expiry dates also influenced doctors to prescribe injections
regardless of actual indications.
Conclusions: As far as the patients and providers’ safety is concerned, this study demonstrated a need for further
research exploring the dynamics of injection use and safety in Bangladesh. In a context where a high level of
injection use and unsafe practices were reported, immediate prevention initiatives need to be operated through
continued intervention efforts and health providers’ training in primary care hospitals in Bangladesh.
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Unsafe injection practices have an inherent risk of spread-
ing three preventable primary blood borne viral (BBV)
pathogens; human immunodeficiency virus (HIV), hepati-
tis B virus (HBV) and hepatitis C virus (HCV) [1,2]. Pre-
ference of injections to oral medications and widespread
misuse of injections in many developing countries has
long been of great concern to health professionals and the
World Health Organization, but so far little systematic
research has been conducted into this world-wide practice.
Available information suggests that the use of injections in
developing countries is common and often unnecessary
[3,4].
Further, unsafe injection practices, such as reuse of con-
taminated needles and syringes in many parts of the
world, are also common [5-7]. In developing countries, the
estimated number of injections per person per year is 3.4
(range 1.7-11.3) and the proportion of unsafe injections is
estimated to be 39% (range 1.2-75%) [3]. In some coun-
tries of South Asia the estimate is as high as 75% [3]. A
number of studies in India and Pakistan have identified
unsafe injection practices [5,6,8,9], and BBV infections
have been attributed to unsafe injection practices [9-11].
Recently, a small-scale study conducted in few primary
health care hospitals in Bangladesh has found very high
rates of misuse and unsafe practices. The study estimated
that some 60% - 80% of used injections were either unne-
cessary or avoidable - e.g. antibiotic injections were used
to treat diarrhea or antihistamine injections used for skin
disease [12]. Such practices are clearly exposing a huge
number of patients to the risk of BBV infections [7]. In
addition, it drains scarce financial resources from both the
private and public sectors. Very limited information is
available to provide an evidence-based understanding on
the national picture of injection practices in Bangladesh.
A recent intervention study using monitoring-training-
planning (MTP) strategy (an intervention which combines
managerial, educational and regulatory strategies) [4]
showed that the intervention has reduced the use injec-
tions in some health complexes in Bangladesh [13]. The
intervention results are only indicative rather than confir-
matory owing to lack of proper expertise, trained person-
nel, funding and sound methodology; and a small sample
size in limited study areas. Therefore, a well designed
study was needed in order to provide an evidence-based
understanding of injection practices in Bangladesh and to
develop appropriate interventions to promote safe injec-
tion practices with an aim to reduce the associated risk of
BBV infections that are transmitted through unsafe injec-
tion procedures [3,10,14].
The current study assessed injection practices in
selected Upazila Health Complex (UHC) hospitals from
all six geographical divisions in Bangladesh. It was a
fundamental need in a country where a high prevalence
of HBV (5.5%-10%) and HCV (2.8%-3.6%) have been
documented among general population [15-19]. The
threat of HIV infection is also looming in Bangladesh,
as the country is geographically surrounded by high
HIV prevalence neighboring states of India and also by
Myanmar with high rates of cross-border migration
[20]. Epidemiologically, Bangladesh is currently moving
towards a ‘concentrated HIV epidemic’ state with an
increasing prevalence of HIV (7.1%) among injecting
drug users in Dhaka [21]. Misuse and unsafe injection
practices may further facilitate epidemic spread of these
BBV infections. The purpose of this study was: to exam-
ine the extent to which injections were used in UHCs in
Bangladesh, the indications for which they were given,
the type and degree of improper and unsafe practices in
the process of administration of injections, the way in
which they were perceived, and the extent to which
facilities in the study areas meet necessary requirements
for practices, equipment and waste disposal procedures.
An additional objective was the development of an
intervention to promote injection safety practices.
Methods
Study design
An observational study was designed which employed
both quantitative and qualitative research methods. The
study was conducted between May 2008 and February
2009 and consisted of three components: i) a retrospective
audit of prescriptions to determine injection use patterns;
ii) systematic observation of UHCs facilities, injection pro-
viders, waste handlers, and injection administering events
to assess how injection safety measures were followed; and
iii) six focus group discussions (FGDs) with doctors and
38 in-depth interviews (IDIs) with doctors, nurses, and
waste handlers on injection safety practices. Qualitative
data supplemented the quantitative findings for practices
that were not identified in the survey.
Study sites
This study took place in 24 primary health care centers
(known as Upazila Health Complexes) of six divisions in
Bangladesh. Geographically Bangladesh is divided into six
divisions (namely Dhaka, Chittagong, Khulna, Rajshahi,
Sylhet and Barisal). We randomly selected four Upazila
Health Complexes (UHCs) from each of these geographi-
cal divisions. The UHCs are government health facilities
located at sub-district level and offer mostly primary (in
limited areas provide secondary level care) health care.
Each UHC serves an estimated population of 0.5 million
in rural Bangladesh. We excluded district level (which
provides secondary level care) and Medical College Hos-
pitals (provides tertiary level care) from this study, as our
focus of interest was to assess injection practices in pri-
mary health care settings.
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The questionnaire for prescription audit and injection
safety observation tools were developed based on pre-
vious research tools [12,22,23], which have been modified
in accordance with the World Health Organization
(WHO)/Safe Injection Global Network (SIGN) recom-
mended revised Injection Safety Assessment Tool [24].
In addition to socio-demographic characteristics, the
survey instrument included information on injection pre-
scribing pattern and safety practices. The indicators
included; total number of prescribed medications per
patient, total number of injections used per prescription,
percentage of prescribed injections per prescription, injec-
tion use rate (percentage of patients who received one or
more injection), percentage of injection used in certain
tracer health conditions (e.g. diarrhea, skin disease, fever),
percentage of injection prescribed in specific health condi-
tions, frequency distribution of types of injections (e.g.
antibiotics, intravenous fluids, pain killers/analgesics, anti-
histamines) given per tracer condition.
As outlined in WHO/SIGN revised Injection Safety
Assessment Tool [24], injection safety practices were
observed under four sub-categories, such as indicators for:
i) health facilities and general safety for heath workers,
recipients and community (e.g. proportion of facilities
where injection safety or waste management policy/guide-
lines were available for viewing, percentage of facilities
with no overflowing or pierced sharps containers, percen-
tage of facilities with no used sharps in an open container
or open areas, proportion of facilities with safe final waste
disposal methods); ii) injection providers’ safety (e.g. per-
centage of providers: reported needle stick injuries in the
last six months, who were trained in injection safety prac-
tices, who were immunized against hepatitis B); iii)
patients/injection recipients safety (e.g. percentage of facil-
ities with no used sharps in open areas, percentage of
events providers maintained antiseptic procedure, percen-
tage of events where a new syringe- needles were used
every time, percentage of recipients who reported a
adverse event, percentage of adverse events followed up
after injection procedures); and iv) safety of waste handlers
(e.g. percentage of waste handlers: have had access to and
used ‘heavy protective gloves’, received formal training in
healthcare waste management in the last two years, fully
immunized for hepatitis B, and reported needle stick
injury in the last six months).
To facilitate data collection for interviews and focus
groups two separate topic guides were developed for IDIs
and FGDs respectively. The guides covered a range of
issues like providers’ perspectives on injection uses; justifi-
cations of injection uses; causes of unsafe injection prac-
tices; risk perceptions; present knowledge and practices on
injection safety (they included knowledge about risk of
needle stick injury, diseases likely to be transmitted,
individuals at risk etc.); syringes and needles disposal;
types of syringes available; monitoring and regulatory
mechanism related to safe injection use; and barrier to
safe injection practices.
The draft data collection tools for all components of
the study were piloted in one health facility in Dhaka,
which resulted in a number of modifications. The final
version was written in English and then translated into
Bengali. Finally, the Bengali version was back-translated
into English to check for linguistic validity of the tools.
Definitions
For the purpose of this study we considered injections
as any medications that were injected either intrave-
nously or intramuscularly or subcutaneously; we also
included intravenous (IV) fluid administration.
The injection use rate in a facility was defined as the per-
centage of prescriptions at a certain health facility that list
at least one or more injections. It was expressed as: Num-
ber of prescriptions examined during the study period con-
taining at least one or more injections/Total number of
prescriptions examined in a certain facility × 100. The
injection use rate per prescription was defined as the per-
centage of injection prescribed per patient’s prescription.
Safe/unsafe injection: An injection was considered safe if
it did not harm the recipient, did not expose the provider
to any avoidable risks and did not result in waste that is
dangerous for the providers, recipients and community
[25,4,23,24]. On the contrary, an injection was therefore
considered unsafe if it harmed the recipient, exposed the
provider to any avoidable risks and resulted in waste that
was dangerous for the providers, recipients and
community.
Injection safety was defined as practices that intended
to prevent transmission of infectious diseases between
one patient and another, or between a patient and
healthcare provider, and also to prevent harms such as
needle-stick injuries, and to ensure safe environment for
providers, patients and community through appropriate
management of dangerous medical waste [23,24].
Sampling and data collection
A research team consisting of eight trained research
assistants (postgraduate pharmacy and medical students)
collected survey and observation data of the study. Moni-
toring and supervision was provided by the principal
investigators (AKAC and CA) and other members of the
investigation team (co-investigators). The interviews and
focus groups data were collected by co-investigators with
supports from the research assistants.
Gaining access to the research sites
In order to gain access to the research sites, we acquired
written permission from the Director General of Health
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Health, Bangladesh. At local level, further discussions
were held between the research team and the local hos-
pital administrators of each site in order to facilitate
data collection process. Based on our initial discussions,
the hospital authorities of each site organized group
information sessions with the representatives from all
categories of service providers, where we informed them
about the research, and the nature and process of data
collection. A written information sheet outlining the
nature of the research and the process of data collection
was also circulated during information sessions. During
specific types of data collection, for example systematic
observations, providers who were being observed were
informed about the research and the nature of the
observations on a one-on-one basis and finally informed
written consent was taken from each of them.
Study component I: retrospective audit of prescriptions
on injection use
We collected retrospective prescribing data on injection
use from hospital records. For sample size calculation,
we assumed an alpha error of 0.05, precision of 5%, a
design effect of 2 and considered prevalence of injection
use as unknown. Considering these assumptions and
including 15% of missing or incomplete data and the
need to adjust for possible confounders, it was deter-
mined that a sample size of 708 from each division was
required for the study. To round up and to cover
further short-fall, we considered 720 prescriptions from
each division, which yielded a total sample size of 4320
for the audit (Figure 1).
A two-stage, cluster-sampling method was used for the
sample size calculation. From the whole country, six geo-
graphic divisions were selected with a probability propor-
tional to population size. As illustrated in Figure 1,
location clusters (24 UHCs) were chosen randomly at the
first stage with equal probability with an aim to enroll 4
facilities from each division (4 × 6 = 24) on the basis of
accessibility, non-ongoing interventions and maximum
scattering across the country. A fixed number of pre-
scriptions (n = 180) was then chosen from each of the
selected clusters (each UHC) with equal probability
based on available list of the patient records (prescribed
between January 2006 and January 2008) and using ran-
dom number tables.
Study component II: systematic observation of injection
safety practices
Prospective data on injection safety practices were col-
lected through observation visits to each of the selected
facilities. The research team members observed each
health facility for 4 hours per day over a period of seven
days. The team observed the activities of 120 injection
providers, 48 waste handlers and 24 hospital facilities to
access how safety measures were followed and to look for
evidence of injection practices. A total of 672 hours of
observation (28 hours per facility) took place in a range
of clinical areas characterized by frequent use of needles
and other sharps, and waste disposal areas. Injection pro-
viders’ and waste handlers’ activities were observed on
the spot based on their availability during the period of
observation visits. We also observed a total of 480 injec-
tions being administered by 120 injection providers.
During each visit injection safety practices were
observed in terms of injection preparation, administra-
tion of injection to the patients and disposal of syringe/
medical waste in order to give a clear understanding of
whether the health providers followed standard guide-
lines or not [22,23].
Study component III: in-depth interviews and focus group
discussions with a range of providers
This phase of the study involved in-depth interviews (IDIs)
with the doctors, nurses and waste handlers, and FGDs
with doctors of 24-UHCs to explore issues that were
unanswered from the audit and/or observation data, and
to supplement the findings of each other components.
Potential participants for IDIs and FGDs were recruited
either through convenience or network sampling techni-
ques during audit or observation visit to the facilities. A
total of 38 semi-structured interviews with doctors (n =
18), nurses/medical assistants (n = 14) and waste handlers
(n = 6) of UHCs and six FGDs (with 5-7 doctors in each
group, n = 43) were conducted in the local language. All
in-depth interviews and focus groups were audio recoded.
Informed consent was requested from each participant
and those who agreed were interviewed. The study proto-
col was reviewed and approved by the experts and review
committees at the University of Dhaka, Bangladesh and
the University of Nottingham, United Kingdom.
Data analysis
All statistical analyses were conducted using SPSS ver-
sion 15 (SPSS Inc., Chicago). Calculations of frequen-
cies, proportions, and c
2 tests were used to assess the
significance of relationships between outcomes and
explanatory indicators.
All qualitative data sources (interviews, focus groups,
field observation notes) were assembled and interview
tapes were translated and transcribed verbatim. After
becoming familiar (that involves reading and re-reading
of transcript texts, reviewing notes) with the content of
texts, we identified a thematic framework that enabled us
to recognize emerging themeso ri s s u e si nt h ed a t as e t
[26]. Extensive discussions were held between the mem-
bers of researcher team to explore the key themes. On
the basis of these discussions, we developed coding
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cer’s framework approach [26] and entered data from all
sources into these. As far as the approach is concerned,
during the analysis stage we sifted, charted and sorted
gathered data in accordance with key issues and themes.
We then identified sections of the data that correspond
to a particular theme and placed the specific pieces of
indexed data in charts that consist of the headings and
subheadings (drawn during the thematic framework).
Finally, we mapped and interpreted the analysis of the
key characteristics as laid out in the charts [26]. This rig-
orous process allowed us to identify key themes, explore
discourses, and compare these across data and/or respon-
dents, and to generate new ideas where appropriate.
Results were then compared and discrepancies were dis-
cussed with the wider group, and concepts were further
refined.
Finally, qualitative data was organized, and the central
themes/findings were constantly compared and combined
with results of quantitative data to see how findings
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Audit of prescriptions: two-stage cluster sampling method: 
clusters and prescriptions chosen with equal probability  
Required sample 
size for each of 
six geographical 
divisions,  
n = 720 
Total number of 
prescriptions 
being assessed 
in 24 UHCs, 
n = 4320 
Hospital facilities 
n = 24 
Service providers 
n = 5 x 24 = 120 
Waste handlers 
n = 2 x 24 = 48 
Injection events 
n = 4 x 120 = 480 
Six focus groups with 
doctors: convenient & 
network sampling  
In-depth interviews: 
convenient & network 
sampling 
Study 
component III 
Study 
component I 
Study 
component II 
Systematic observations of injection safety practices:   
Team members, n = 8; Total number of visits per facility, n = 7 [each facility was 
observed for 4 hours per visit over a period of 7 days]    
Approached, n = 53 
Agreed, n = 46 
Attended, n = 43   
Doctors: 
Approached 
(n = 26) 
Agreed  
(n = 23) 
Attended  
(n = 18)   
Injection 
providers:  
Approached 
(n = 18) 
Agreed  
(n = 15) 
Attended  
(n = 14)   
Waste handlers: 
Approached 
(n =7) 
Agreed  
(n = 6) 
Attended  
(n = 6)   
 
Equal number of 
prescriptions 
assessed 
randomly per 
facility, n = 180 
Total facilities 
randomly chosen 
with equal 
probability,  
n = 24 
Figure 1 Flow of participates through the study (sampling & recruitment).
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data sets were then analyzed in relation to wider perspec-
tives of injection uses and injection safety practices (locally
and where applicable internationally).
Results
The extent of injection use
Table 1 shows the extent of injection use patterns in six
divisions of Bangladesh. Injections were given in more
than three quarter (77.7%, n = 3354) of the studied illness
cases in the health facilities. Among the six divisions, the
injection use rates were the highest in the UHCs of Chitta-
gong division (94.2%) and lowest in the UHCs of Dhaka
division (60.2%). The average number of injections per
patient per prescription was 2.7 (range 1.0 - 4.3). This was
also the lowest in UHCs of Dhaka division (average 1.0)
and the highest in UHCs of Khulna division (average 4.3).
As shown in Table 2, the most commonly used injec-
tions included antibiotics (78.3%), IV fluids (38.6%),
analgesics/pain killers (29.4%), vitamins (26.7%), and
anti-histamines (18.5%). The injections were frequently
used to treat acute watery diarrhea (36.7%), general
weakness (19.4%), skin infections/itching (15.4%), fever
(13.6%) and traumatic injuries (11.2%).
Table 3 further investigates indications for which speci-
fic categories of injections were given. Among 2626 cases
where antibiotics were prescribed, 43.7% (n = 1145) was
prescribed to treat acute watery diarrhea. Further, vitamins
(91.7%) and anti-histamines (73.6%) injections were fre-
quently used for general weakness and skin infections
respectively. Where IV fluids were used (n = 1295), 42.3%
(n = 600) of them were used to manage non-specific con-
dition such as general weakness.
Injection safety practices
Table 4 demonstrates injection safety practices in the
UHCs of Bangladesh. In general, none of the health facil-
ities (n = 24) observed had injection safety and waste dis-
posal policy or guidelines available for viewing. Immediate
disposal of used needles and syringes in a puncture proof
sharps container or use of a needle remover was not
observed in more than two-third (81.5%) of the health
facilities. Only in 16.5% of all facilities (n = 24) syringes
and needles were disposed of in a puncture proof con-
tainer and of those 55% facilities in Dhaka, 36.3% in Chit-
tagong and 20% in Rajshahi division used puncture proof
containers for sharp materials disposal. None of the facil-
ities in Sylhet, Barisal and Khulna division had any punc-
ture proof containers at all to dispose of sharp materials.
We observed that overflowing sharps container were
found in 78% of the UHCs and in 80.7% of the facilities
there were loose injection materials scattered around the
open areas. Only 16.2% of the facilities were found with
safe final waste disposal methods. Further, during
observations we found that used syringes and intravenous
fluid bags (drips) were scattered around, not only at health
facility waste sites but also inside the hospital buildings
(including consultation areas and wards) as well. In as
many as 89.2% sites we found that children were playing
with used syringes and intravenous fluid bags.
Further, providers were not trained in injection safety
practices and medical waste management. It was noted
that 87.5% of the injection providers (n = 120) in the
health facilities of Dhaka division and 75% in Rajshahi
division have received some sort of training in injection
safety practices, but none of the providers in the UHCs of
all other study sites in Khulna, Chittagong, Barisal and Syl-
het division were trained. Similarly only 50% of the waste
handlers (n = 48) in Dhaka division and 12.5% in Sylhet
division were trained in healthcare waste management.
Moreover, in all observed facilities none of the waste
handlers have had access to “heavy protective gloves”.
We also observed a total of 480 injection events being
administered by 120 injection providers (4 events per
provider) to look at how safe the processes were for the
injection recipients and also for the injection providers in
real practice. Findings demonstrated that none of the
injection providers washed their hands properly with
antiseptic soap or used alcohol based rub in UHCs of
Chittagong, Rajshahi, Khulna, Sylhet and Barisal division.
T h eo n l ye x c e p t i o nw a so b s e r v e di nD h a k ad i v i s i o n
where 33.5% providers did so. In contrast, when we
asked individually during interviews almost all providers
reported that they have washed their hands properly with
antiseptic soap or used alcohol based rub.
All service providers (100%) in UHCs of Dhaka division
cleaned or wiped the injection site with rectified spirit
before providing injections, but this practice was very
poor in all other divisions (ranged from 8.8% in Rajshahi
division to 30% in Sylhet division). In 84.5% of all injec-
tions being administered (n = 480), the injection provi-
ders used new syringes and new needles. However, in
15.5% events we observed the providers reused the same
syringes and needles up to three times (specifically for
very poor patients). The unsafe practices of reusing con-
taminated needles and syringes were higher in UHCs of
Sylhet Division (25.5%) than other divisions (between
2.0% and 17.5%). Further, in 35% of all injection events
(n = 480), the injection providers did not always prepare
the injections on a clean table or tray.
Needle-stick injuries were common with 67.5% of the
injection providers in Rajshahi, 46.3% in Dhaka and
32.5% in Chittagong and Barisal reporting having had
such injuries in the last six months before the survey.
This could be a potential source of transmission of BBV
infections from the infected patients to the injection pro-
viders. On the other hand, none reported such injuries in
Khulna and Sylhet division. On further investigation
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that only 23% of injection providers (n = 120) and 4.2%
of the waste handlers from all study sites were fully
immunized against hepatitis B virus (all 3 doses
completed).
Contextual factors contributing to popularity of injections
and unsafe injection practices
Qualitative data also revealed that injections were pre-
scribed to most of the patients. Most doctors reported
treating 50-60 patients per day (including patients in
their private practice). In most of cases injection were
prescribed and diagnosis were made based on only clini-
cal presentation of the cases. They were rarely sup-
ported by any laboratory investigations. Hence providers
often have made decisions for prescribing antibiotic
injections based on their clinical judgments and
perceived seriousness of the diseases. During in-depth
interviews and FGDs with doctors and health assistants
the respondents mentioned that their perception of the
seriousness of the disease may not be the correct one as
they were hardly ever supported by standardized, evi-
dence-based treatment protocols for the treatment of
common illnesses.
The reason behind the popularity of injections was
fairly complex and is summarized below.
Disease conditions where injections were frequently
used
￿ Watery diarrhea/dehydration
￿ General weakness
￿ Skin infections
￿ Fever/pyrexia of unknown origin
￿ Road traffic accidents and assault cases
Table 1 The extent of injection use patterns in selected UHCs of six divisions in Bangladesh
Facilities Injection use rate (%) No. of injection/person (SD)
Dhaka Division (n = 720) 60.14 1.04 (± 0.03)
Mirzapur UHC (n = 180) 70.39 1.47 (± 0.05)
Kaliakoir UHC (n = 180) 61.90 1.07 (± 0.02)
Gazaria UHC (n = 180) 57.80 0.98 (± 0.01)
Bondor UHC (n = 180) 50.47 0.62 (± 0.05)
Chittagong Division (n = 720) 94.18* 3.92 (± 0.12)
Anoara UHC (n = 180) 98.33 5.72 (± 0.16)
Sitakunda UHC (n = 180) 93.89 2.33 (± 0.09)
Manikchari UHC (n = 180) 92.83 3.30 (± 0.11)
Rangunia UHC (n = 180) 91.67 4.34 (± 0.14)
Rajshahi Division (n = 720) 70.92 2.26 (± 0.08)
Durgapur UHC (n = 180) 76.99 2.80 (± 0.10)
Bagmara UHC (n = 180) 74.19 2.67 (± 0.09)
Godagari UHC (n = 180) 67.50 1.69 (± 0.06)
Puthia UHC (n = 180) 65.00 1.88 (± 0.07)
Khulna Division (n = 720) 82.92 4.26 (± 0.13)
Tala UHC (n = 180) 95.00 6.75 (± 0.18)
Avoynagar UHC (n = 180) 90.00 5.48 (± 0.16)
Batiaghata UHC (n = 180) 69.44 2.36 (± 0.09)
Fultala UHC (n = 180) 77.22 2.45 (± 0.09)
Batiaghata UHC (n = 180) 69.44 2.36 (± 0.09)
Sylhet Division (n = 720) 82.36 2.15 (± 0.08)
Chatak UHC (n = 180) 96.67 2.40 (± 0.09)
Fenchugonj UHC (n = 180) 86.66 2.70 (± 0.10)
Bianibazar UHC (n = 180) 73.33 1.60 (± 0.06)
Golapgonj UHC (n = 180) 72.77 1.90 (± 0.07)
Barisal Division (n = 720) 75.42 2.32 (± 0.76)
Gournadi UHC (n = 180) 93.89 2.56 (± 0.09)
Uzirpur UHC (n = 180) 81.67 3.27 (± 0.11)
Nalchiti UHC (n = 180) 79.44 2.27 (± 0.08)
Babugonj UHC (n = 180) 46.66 1.16 (± 0.03)
Total (n = 4320) 77.65 2.66 (± 0.08)
UHC, upazila health complex; SD, standard deviation; *p < 0.01.
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Page 7 of 13￿ Reparatory infection/pneumonia
￿ Abdominal pain/peptic ulcer
Reasons behind popularity of injections
￿ Local beliefs about illness and concepts of efficacy
￿ Perceived severity of the disease (doctors
perspective):
- Doctors’ belief that injections are more effective
than oral medications
- Perceived seriousness of the diseases by the
doctors often motivated them to use injection
- A perception that serious conditions need ser-
ious and “powerful medication”
￿ Doctors’ own quest to prove their superiority over
other doctors through prescribing so called high-
cost “powerful medications”.
￿ Lack of patient-provider communication.
￿ The sensitivity of the patients’ condition
￿ Patients’ demand
- A desire to get quick relief: mostly derived
from the perceptions that injections are the sure
way to quick relief
- A perception that injections are necessary in a
good prescription
- A notion to justify strong police cases against
the offenders (in case accident/assault incidences)
￿ Pressure from hospital authority
- To use up the injections before their expiry
dates
- To release in patients from the hospitals as
quickly as possibly
(affecting doctors prescribing behavior to treat
patients more aggressively with injections)
￿ Prescribing and dispensing by the medical assis-
tants/paramedics
- A tendency to over-prescribe injections
- Prolonged absence of doctors from hospitals
- Emergency case management in absence of
doctors
Table 2 Types and patterns of injection use
Variables Injection use rate (%)
Percentage of injection use vs.
other medications (n = 4230)
Injections only 68.7
Oral medications only 20.8
Injections and oral medications 10.2
Other medications 1.3
Types of Medications (n = 3354)*
Antibiotics 78.3
Intravenous fluids 38.6
Analgesic/pain killers 29.4
Vitamins 26.7
Anti-histamines 18.5
Sedatives 13.4
Anti-malarial 08.6
Others 24.8
Number of injections per prescription (n = 3354)
1-2 32.8
>2 67.2
*Adds up to more than 100% because analysis is derived from the analysis of multiple responses using Statistical Package for the Social Sciences.
Table 3 Types of injection used vs. health conditions
Health conditions/Types of
injection used
Antibiotics
(N = 2626)
IV fluids
(N = 1295)
Analgesics/pain killers
(N = 986)
Vitamins
(N = 896)
Anti-histamines
(N = 620)
% (n) % (n) % (n) % (n) % (n)
Acute Diarrhea 43.7 (1145) 31.4 (407) - - -
General weakness - 42.3 (600) - 91.7 (822) 5.7 (35)
Skin infection/itching 23.5 (617) 4.8 (62) 5.2 (51) - 73.6 (456)
Fever 22.7 (596) 14.5 (188) 63.4 (625) 3.6 (32) 9.2 (57)
Traumatic injury/assault/RTA 13.2 (347) 3.4 (44) 22.7 (224) 2.8 (25) 8.5 (53)
RTA, road traffic accident; IV, intravenous.
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Page 8 of 13￿ Economic interests of pharmaceutical companies
- Aggressive marketing/promotional activities
- Attractive gifts offer to the doctors and para-
medics/medical assistants
In both in-depth interviews and FGDs we identified
multiple reasons that shaped the final decision to use
injections by the doctors/medical assistants. Doctors as
well as patients believed that injections work better than
oral medications. In many cases injection use was predo-
minantly influenced by doctors’ beliefs that injections are
more effective than oral medications and their perception
of the seriousness of the diseases often motivated them to
use injections. Doctors’ own quest to prove their super-
iority over other doctors in general practice has
significantly shaped their prescribing behavior and insti-
gated them to use high-cost “powerful medications”
often with an aim for magical cure. In a few cases the
social status of patients also influenced doctors to pre-
scribe injections, for example, if the patient was from an
influential family in the community, doctors prescribed
them injections to show that the patient was being taken
care of seriously.
In many cases patients’ demands also strongly influ-
enced prescribing behavior. Patients’ demand mostly
emanated from their desire to get quick relief and/or a
notion to justify stronger police cases against offenders
(in accident/assault cases, the persons responsible for the
offences). During in-depth interviews with doctors and
providers it was highlighted that such demands from
Table 4 Division-wise injection safety practices in the UHCs in Bangladesh
Indicators Division§ Total
1 23456
A. Facility observation: general safety (n = 24)
Average no. of injections per patient (number) 0.9 3.8 02.3 02.3 02.31 04.3 2.7
Injection safety policy/guidelines was available for viewing (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Waste disposal policy/guidelines was available for viewing (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Waste handlers have access to ‘heavy gloves’ (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Facilities with no non-sharps infectious waste outside (%) 23.5 16.3 11.6 0.0 0.0 0.0 8.6
Used syringe, needle disposed in puncture proof box (%) 55.0* 36.3 20.0 0.0 0.0 0.0 16.5
Facilities with no loose sharps/needles overflowing (%) 36.5 48.3* 47.5 0.0 0.0 0.0 22.0
Facilities with no loose injection materials scattered (%) 23.8 40.0* 26.5 0.0 11.2 15 19.4
Facilities with safe final waste disposal methods (%) 31.5 12.5 21.5 10.12 0.0 21.3 16.2
B. Injection providers’ safety (n = 120)
Providers reported needle stick injuries in last 6 months (%) 46.3 32.5 67.5* 0.0 32.5 0.0 29.8
Providers trained in injection safety practices in last 2 years (%) 87.5* 0.0 75.0 0.0 0.0 0.0 27.1
Providers have had at least one Hepatitis B vaccination 3.6 27.3 13.7 53.4 47.6 0.0 24.3
Immunized against HBV [all 3 doses] (%) 02.5 25.0 12.5 52.5* 45.0 0.0 22.9
C. Safety of the recipients (n = 480)
Providers washed hands with antiseptic soap/rub (%) 33.5* 0.0 0.0 0.0 0.0 0.0 05.6
Patients whose injection site sterilized by spirit (%) 100.0* 0.0 08.8 30.0 20.0 12.5 28.5
Used new syringe- needles for reconstitution (%) 98.0 88.5 80.7 74.5 83.0 82.5 84.5
Injection was prepared on clean table (%) 56.5 0.0 05.0 50.0 80.0* 18.8 35.0
Used syringe, needle disposed immediately after injection 55.0* 36.3 20.0 0.0 0.0 0.0 18.5
No used sharps were scattered in open areas 27.8 36.0* 22.5 4.5 11.2 14.7 18.8
Followed adverse events after injection (%) 13.8 0.0 0.0 0.0 30.0* 0.0 07.3
D. Safety of the waste handlers (n = 48)
Waste handlers used ‘heavy gloves’ (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Trained in healthcare waste management (%) 50.0* 0.0 0.0 12.5 0.0 0.0 10.4
Immunized with HBV vaccine [3 dose] (%) 9.7 6.5 0.0 08.8 0.0 0.0 4.2
Waste handlers used any form of gloves (%) 62.5* 0.0 0.0 0.0 0.0 0.0 10.4
Reported needle stick injury in last 6 months (%) 46.5* 20.5 27.5 16.3 30.6 10.8 25.4
HBV, hepatitis B virus; §1 = Dhaka, 2 = Chittagong, 3 = Rajshahi, 4 = Sylhet, 5 = Barishal, 6 = Khulna.
* p < 0.01.
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Page 9 of 13patients were mostly derived from the perceptions that
injections are the sure way to quick relief. Doctors
further mentioned that patients believed that injections
are necessary in a good prescription. Hence a prescrip-
tion without injections was not considered as a good
prescription. In few cases an intention for better compen-
sation and/or litigation aspects to justify documentary
seriousness of the incidents like assault motivated
patients to demand for injections.
Further, pressure from the health/hospital administra-
tion to use up the injections before their expiry dates,
influenced the doctors to prescribe injections regardless
of actual indications. During focus groups the doctors
mentioned that there was also a persistent pressure from
the hospital administration to release inpatients from the
hospitals as quickly as possible to clear the beds for allo-
cating them to new patients. Such pressure often affected
doctors’ prescribing behavior making them treat patients
more aggressively with injections to attempt to cure
them as quickly as possible.
It was revealed that in the absence of doctors medical
assistants were required to take responsibility for hand-
ling patients and prescribing in many cases. The doctors
highlighted that the medical assistants tended to overuse
injections. These practices were common as some of the
doctors remained absent from the health complexes for
long periods of time.
It was also noted that aggressive marketing or promo-
tional activities of injection products by the medical
representatives of pharmaceutical companies have a sig-
nificant influence on the prescribing behavior of the
doctors. In many cases, the pharmaceutical companies
offered very attractive gifts to the doctors and parame-
dics to prescribe their medicines. Such aggressive mar-
keting techniques have had a significant influence on
overuse of injections by the doctors.
Discussion
In our audit of prescriptions, high rates of injection use
were observed in the primary care hospitals in Bangladesh.
More than three quarters of the total prescribed medica-
tions were injections and the majority (78.4%) of
prescribed injections was antibiotics followed by IV fluids.
The results further indicated that this high rate of injec-
tion use cannot be bio-medically justified. Antibiotics were
frequently used to treat conditions like diarrhea and IV
fluids, and even to manage non-specific conditions like
general weakness. Further, high rates of injection use even
in such uncomplicated, non-severe and self-limiting ill-
nesses, indicating medical inappropriateness of injection
use. Previous research in other developing country settings
suggests that the misuse of injections remains high due to
the false assumption of prescribers that injections will
improve patient satisfaction and that they are always
expected by the patients [27-29]. Supporting the findings
from previous research in other settings, our research illu-
strated that both prescribers and the patients consider the
inclusion of injections in a prescription as standard prac-
tice [4,6,8,9,27].
The injection use pattern was almost the same in most
of the facilities studied except in the UHCs of Dhaka
division, which was lower than other divisions. The injec-
tion safety practices indicators were also comparatively
better in Dhaka. This may be due to the fact that there
had been a few previous interventions implemented to
reduce misuse and promote safe injection practices in the
selected UHCs of Dhaka [12,13]. The authors of the
study with the funding support from the WHO/SIGN
project implemented MTP intervention in 2004/2005 in
4 UHCs (these 4 UGCs were also included in our current
study) of Dhaka. It is interesting that the impact of pre-
vious interventions appear to have remained positive for
some of the safe injection practice indicators in those
facilitates in Dhaka division. This indicates a need
to introduce similar interventions in other UHCs in
Bangladesh. Such interventions should combine manage-
ment, educational and regulatory strategies [4] and
ensure health providers’ safety, for example, they should
include training in safe injection practices for both injec-
tion providers and waste handlers, improve supportive
supervision of health facilities and the processes aiming
to improve safe injection practices should be regularly
monitored [12,13,29].
Consistent with findings from other settings, our obser-
vations suggests that injections were often not provided
in safe and hygienic ways [4,6,8,29-31]. Sharps injuries
happened frequently among injection providers and med-
ical waste handlers. Surprisingly, a higher level of training
of the health workers was not translated into safer injec-
tions practices. For example, the facilities in Dhaka were
those most likely to dispose of used needles in a punc-
ture-proof box, the most likely to have safe final waste
disposal methods, and it was the only division where
most of the staff had received training in injection safety,
but they reported the second highest proportion of injec-
tion providers with needle stick injuries, and the highest
proportion of waste handlers with needle stick injuries.
Although we do not have any insight into why some of
the other sites reported no needle stick injuries amongst
the injection providers and waste handlers despite poor
practices, qualitative data give us some explanations
about this. During our in-depth interviews the injection
providers in Dhaka frequently mentioned that the patient
turn over in Dhaka is higher than other areas. As a result
providers in these facilities have to work in a very busy
environment and always rush to provide services, which
make them more prone to accidental incidents like nee-
dle stick injuries as reported. They may also be more
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Page 10 of 13likely to report needle stick injuries because they have
been trained.
Further, providers were not aware of the risks asso-
ciated with unsafe injection practices. A lack of aware-
ness on the part of health care workers about the risk of
B B Vd i s e a s e st r a n s m i s s i o ni nhealth care settings even
with or without reuse of non-sterile equipment may
explain a number of practices allowing for cross contami-
nation that expose both injection providers’ and recipi-
ents to infections. There was no culture to promote self-
protection or to train providers in terms of safety prac-
tices. In addition, there were shortages in supply of dis-
posable syringes and needles and other essential
equipment required to practice injection procedure safely
and hygienically. Most of the time patients need to buy
their own disposable syringes from a private pharmacy.
Poor patients, those who were unable to buy their own
disposable syringes and needles, were most frequent vic-
tims of syringes and needles reuse (injection provider
often administered injection to them using syringes and
needles that had been used for other patients before). In
the Bangladeshi setting where HBV and HCV infection
have a high endemic profile and where injections are
misused and/or overused, such breaks in infection pre-
vention practices may be sufficient to transmit BBV
infections from patient to patient through injections.
Poor immunization against HBV and lack of training in
injection safety and waste disposal has further precipi-
tated the risk of infection [12,29].
From the view point of safety of the patients, health pro-
viders, waste handlers and the community, the injection
practices were unsafe in all of the study facilities in terms
of many indicators. Moreover, puncture-proof containers
and heavy protective gloves for waste handlers were lack-
ing, and medical waste was not disposed of properly.
Thus, the risk of needle-stick injuries is increased, hence
increasing the risk of BBV infections transmission through
contaminated needles. Similar findings were reported in
previous studies in different settings [30,31]. The presence
of sharp waste in the environment also indicates that
Bangladesh’s medical waste management infrastructure
needs to be strengthened.
In our in-depth interviews and FGDs, most doctors and
medical assistants reported that patients, particularly older
persons in rural areas, prefer injections for common medi-
cal conditions. This finding is consistent with result of
other studies in different settings [9,13,27,28]. However, a
number of elements suggested that health care workers
significantly contribute to injection misuse or overuse.
These include: a tendency of physicians’ to provide ratio-
nalized and “scientific” explanations to justify their mis-
use/overuse; economic incentives from pharmaceutical
companies; limitation of standardized and evidence-based
treatment protocols for common illnesses, safety practices
and medical waste management; and the persistence of
inappropriate policies and pressure from hospital authori-
ties. Echoing with the results from other studies our find-
ings suggest that practitioners think patients want
injections and this demand prompts them to administer
more injections than they deem necessary to remain popu-
lar in a competitive health care market [4,9,27,28]. As a
result, patients think that far more injections are required
than are actually needed. A clear patient-provider commu-
nication gap exists in this issue.
The data presented here reflects the present situation in
injection practices in primary care hospitals in Bangladesh.
At this stage, we do not know what is ideal or the gold
standard. No data are available regarding the association
between the misuse of injections and infections in Bangla-
desh or elsewhere. Given that high levels of avoidable
injection use in Bangladeshi hospitals, the study demon-
strates a need for further research to explore the dynamics
of injection safety practices and relationships between
injections and resulting infections in different hospital
contexts, and suggests a need for prevention efforts to pro-
mote safe and rational injection use in primary care hospi-
tals in Bangladesh.
A lack of concern for the management of health care
waste associated with an absence of a waste treatment
infrastructure may result in the presence of sharps waste
in the environment. Supportive supervision for health
workers will strengthen safe injection practices and related
waste management. Policy makers and implementers
should focus on prevention initiatives in order to promote
and ensure safe injection use and practices in primary care
hospitals in Bangladesh.
Limitations of the study
While the current study contributes important informa-
tion likely to aid in the design of relevant policies, and to
guide future research and programmatic efforts relevant
to injection practices in Bangladesh or elsewhere, it must
be considered in light of a number of study limitations.
We acknowledge the general limitations of using retro-
spective data. The use of retrospective information rather
than prospective longitudinal data for our prescription
audit may limit the generalization of our findings.
Further limitations include the inability to generalize
our result to other parts of Bangladesh because it is prob-
able that given the variability of injection practices within
districts (as demonstrated by our study), there is also
likely to be considerable and unpredictable variability
between districts. Data presented in our analyses were
based on only the service provider’s perspective of injec-
tions use; therefore, this may not essentially represent the
patient’s perspective of injections use. For example,
claims were made by health care workers that patients
preferred injections, but the patients were not actually
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Page 11 of 13interviewed or included as participants in IDIs or FGDs;
this could add richness and complexity to the findings of
future studies. The fact that the injection providers and
waste handlers knew they were being observed may have
influenced their injection practices, but this is most likely
to have influenced them to practice more carefully and
safely rather than less.
Strengths of the study
Despite these limitations, our study has some strong
grounds to justify the validity of the results. Our data
were drawn from a mixed-method study involving a ret-
rospective audit of prescriptions, systematic observation
of injection safety practices, and FGDs and in-depth
interviewers with a range of hospital workers. We con-
sider this triangulation of data sources as a potential
strength of our study, which enhanced the validity of the
findings. The in-depth interviews and focus groups data
supplemented the survey and observation findings (and
vice versa), thus providing richer interpretation to the
results. Our systematic observations also helped to con-
textualize the interview and focus group data and allowed
the findings to go beyond the subjective perceptions of
the interview participants. On the other hand, the inter-
views and focus groups gave depth to the observations
and survey results by providing the doctors, injection
providers and waste handlers with an opportunity to
describe and interpret their experiences in relation to
injection use and safety, and to share their views regard-
ing reasons for misuse/overuse of injections and unsafe
practices.
Conclusion
As far as the patients and providers’ safety is concerned,
this study demonstrated a need for further research
exploring the dynamics of injection use and safety prac-
tices in Bangladesh. In a context where a high level of
injection use and unsafe practices were reported,
immediate prevention initiatives need to be operated in
order to promote safe injection practices in primary care
hospitals in Bangladesh. Such an intervention should
include components like, i) establishing clear rules and
regulations for the use of injections in medical practice
and promoting evidence-based practice; ii) ensuring
appropriate logistics (e.g. supply of disposables and pro-
tective gloves) and safeguard procedures for injection
providers and waste handlers; iii) improving supervision
of health facilities and monitoring the process aiming to
improve injection safety practices on regular basis; iv)
making health personnel aware of the negative impact of
their injection practice on the spread of BBV; v) proper
training of health care providers in safe injection prac-
tices and safe management of sharps medical waste
through carrying out clean injection program for
providers, including in-service training, refresher courses,
and guidelines; and vi) also carrying out clean injection
program for users, including information, education and
communication (IEC) about the need for hygienic
practices.
Such interventions will only be successful if they con-
sider the underlying perspectives of injection misuse
both for service providers and for users. Therefore, any
policy to be adopted must be based upon good under-
standing of the cultural meaning of injections and best
available evidence, their place in medical practices, and
their influence upon human relations.
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